Co-Authors
This is a "connection" page, showing publications co-authored by Paolo Ascierto and Gennaro Ciliberto.
Connection Strength
1.760
-
ErbB3 Phosphorylation as Central Event in Adaptive Resistance to Targeted Therapy in Metastatic Melanoma: Early Detection in CTCs during Therapy and Insights into Regulation by Autocrine Neuregulin. Cancers (Basel). 2019 Sep 25; 11(10).
Score: 0.211
-
The potential of BRAF-associated non-coding RNA as a therapeutic target in melanoma. Expert Opin Ther Targets. 2019 01; 23(1):53-68.
Score: 0.200
-
Perspectives in melanoma: Meeting report from the Melanoma Bridge (30 November-2 December, 2017, Naples, Italy). J Transl Med. 2018 07 21; 16(1):207.
Score: 0.194
-
Future perspectives in melanoma research "Melanoma Bridge", Napoli, November 30th-3rd December 2016. J Transl Med. 2017 11 16; 15(1):236.
Score: 0.186
-
The need for a network to establish and validate predictive biomarkers in cancer immunotherapy. J Transl Med. 2017 11 03; 15(1):223.
Score: 0.185
-
MicroRNAs in melanoma development and resistance to target therapy. Oncotarget. 2017 Mar 28; 8(13):22262-22278.
Score: 0.177
-
miR-579-3p controls melanoma progression and resistance to target therapy. Proc Natl Acad Sci U S A. 2016 08 23; 113(34):E5005-13.
Score: 0.170
-
Future perspectives in melanoma research: meeting report from the "Melanoma Bridge", Napoli, December 5th-8th 2013. J Transl Med. 2014 Oct 28; 12:277.
Score: 0.150
-
Immunological and biological changes during ipilimumab treatment and their potential correlation with clinical response and survival in patients with advanced melanoma. Cancer Immunol Immunother. 2014 Jul; 63(7):675-83.
Score: 0.144
-
Inhibition of Stearoyl-CoA desaturase 1 reverts BRAF and MEK inhibition-induced selection of cancer stem cells in BRAF-mutated melanoma. J Exp Clin Cancer Res. 2018 Dec 17; 37(1):318.
Score: 0.050
-
Targeting the cross-talk between Urokinase receptor and Formyl peptide receptor type 1 to prevent invasion and trans-endothelial migration of melanoma cells. J Exp Clin Cancer Res. 2017 Dec 08; 36(1):180.
Score: 0.047
-
Phenotype characterization of human melanoma cells resistant to dabrafenib. Oncol Rep. 2017 Nov; 38(5):2741-2751.
Score: 0.046